高级检索
当前位置: 首页 > 详情页

Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization.

| 认领 | 导出 |

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University 157 West Fifth Street, Xi'an 710004, Shaanxi, P. R. China. [2]The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University 277 West Yanta Road, Xi'an 710061, Shaanxi, P. R. China. [3]Institute of Traditional Chinese Medicine, Hunan University of Chinese Medicine 300 Xueshi Street, Changsha 410208, Hunan, P. R. China. [4]Department of Blood, The Chengdu Military Command General Hospital of Kunming Medical University 212 West Daguan Road, Kunming 650032, Yunnan, P. R. China.
出处:
ISSN:

关键词: Baicalein TAMs TGF-β1 EMT breast cancer

摘要:
Tumor associated macrophages (TAMs) are the main infiltrating component in the tumor microenvironment and play an important role in cancer progression. Baicalein has a wide range of pharmacological properties. This study explores the potential effect of baicalein on macrophages polarization and epithelial-mesenchymal transition (EMT) of breast cancer. Co-culture system was established to evaluate the interaction between TAMs and breast cancer cells. Then the role of baicalein in modulating TAMs function was assessed. Finally, breast cancer mouse model was established to study the underlying mechanism. In vitro experiments showed that co-culture with M2 macrophages significantly enhanced EMT of both MDA-MB-231 and MCF-7 breast cancer cells. Baicalein could regulate polarization of M2 and attenuate TGF-β1 secretion. In vivo experiments showed that compared with the MDA-MB-231 + M2 group, tumor growth and metastasis of baicalein + MDA-MB-231 + M2 group was significantly inhibited, with smaller tumor size and decreased lung metastasis lesions. Our findings suggest that the regulation of TAMs may be a novel mechanism underlying the anti-tumor effects of baicalein in breast cancer.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
第一作者:
第一作者机构: [1]Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University 157 West Fifth Street, Xi'an 710004, Shaanxi, P. R. China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University 157 West Fifth Street, Xi'an 710004, Shaanxi, P. R. China. [*1]Department of Oncology, The Second Affiliated Hospital of Xi’an Jiaotong University, 157 West Fifth Street, Xi’an 710004, Shaanxi, P. R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82325 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号